Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era.

Ng, Kenrick; Vinnakota, Krishna; Sharma, Anand; Kelly, John; Dasgupta, Prokar; Vasdev, Nikhil

Ng, Kenrick; Vinnakota, Krishna; Sharma, Anand; Kelly, John; Dasgupta, Prokar; Vasdev, Nikhil.

Ng K; Department of Medical Oncology, UCL Cancer Institute, University College London, London, UK.
Vinnakota K; Department of Medicine, King's College Hospital NHS Trust, London, UK.
Sharma A; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
Kelly J; Division of Surgery and Interventional Science, University College London, London, UK.
Dasgupta P; Faculty of Life Sciences and Medicine, King's College London, London, UK.
Vasdev N; Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage, UK. nikhilvasdev@doctors.org.uk.

Nat Rev Urol ; 18(4): 185-187, 2021 04.

Article in English | MEDLINE | ID: covidwho-989876

Subject(s)

Biomarkers, Tumor/urine; COVID-19/epidemiology; Delayed Diagnosis/trends; Urinary Bladder Neoplasms/epidemiology; Urinary Bladder Neoplasms/urine; COVID-19/prevention & control; Delayed Diagnosis/prevention & control; Humans; Randomized Controlled Trials as Topic/methods; Urinary Bladder Neoplasms/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor / Delayed Diagnosis / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Nat Rev Urol Journal subject: Urology Year: 2021 Document Type: Article Affiliation country: S41585-020-00419-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google